On November 28, 2025, Yungjin Pharm. Co., Ltd. closed the transaction.
Yungjin Pharm. Co., Ltd. announced that it has received KRW 25.1 billion in funding from a group of investors
Published on 11/28/2025 at 09:02 pm GMT
S&P Capital IQ
Share
© S&P Capital IQ -
2025
Share
















